HomeCompareARTRX vs DIVO

ARTRX vs DIVO: Dividend Comparison 2026

ARTRX yields 3.74% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIVO wins by $5.2K in total portfolio value
10 years
ARTRX
ARTRX
● Live price
3.74%
Share price
$31.93
Annual div
$1.19
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$474.89
Full ARTRX calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — ARTRX vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARTRXDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARTRX + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARTRX pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARTRX
Annual income on $10K today (after 15% tax)
$317.51/yr
After 10yr DRIP, annual income (after tax)
$403.66/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, DIVO beats the other by $430.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARTRX + DIVO for your $10,000?

ARTRX: 50%DIVO: 50%
100% DIVO50/50100% ARTRX
Portfolio after 10yr
$28.1K
Annual income
$728.29/yr
Blended yield
2.59%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARTRX buys
0
DIVO buys
0
No recent congressional trades found for ARTRX or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARTRXDIVO
Forward yield3.74%6.49%
Annual dividend / share$1.19$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$25.5K$30.7K
Annual income after 10y$474.89$981.68
Total dividends collected$4.3K$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ARTRX vs DIVO ($10,000, DRIP)

YearARTRX PortfolioARTRX Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$11,074$373.55$11,349$649.42$275.00DIVO
2$12,235$386.59$12,833$688.83$598.00DIVO
3$13,491$399.20$14,459$727.90$968.00DIVO
4$14,847$411.37$16,238$766.49$1.4KDIVO
5$16,309$423.09$18,179$804.47$1.9KDIVO
6$17,885$434.36$20,293$841.71$2.4KDIVO
7$19,582$445.17$22,591$878.14$3.0KDIVO
8$21,408$455.53$25,087$913.65$3.7KDIVO
9$23,372$465.43$27,791$948.18$4.4KDIVO
10$25,483$474.89$30,718$981.68$5.2KDIVO

ARTRX vs DIVO: Complete Analysis 2026

ARTRXStock

The investment seeks maximum long-term capital growth. The fund's investment team employs a fundamental investment process to construct a diversified portfolio of U.S. and non-U.S. growth companies across a broad capitalization range. The team seeks to invest in companies that the advisor believes possess franchise characteristics, are benefiting from an accelerating profit cycle and are trading at a discount to its estimate of private market value.

Full ARTRX Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this ARTRX vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARTRX vs SCHDARTRX vs JEPIARTRX vs OARTRX vs KOARTRX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.